Hematopoietic stem cell transplantation in patients with systolic dysfunction: can it be done?
about
Cardiovascular Complications of Hematopoietic Stem Cell Transplantation.Cardiomyopathy in patients after posttransplant cyclophosphamide-based hematopoietic cell transplantation.Recommended screening and preventive evaluation practices of adult candidates for hematopoietic stem cell transplantation.Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value.Impact of comorbidities constituting the hematopoietic cell transplant (HCT)-comorbidity index on the outcome of patients undergoing allogeneic HCT for acute myeloid leukemia.Pre-transplant diastolic but not systolic dysfunction has a negative prognostic impact after allogeneic stem cell transplantation.
P2860
Hematopoietic stem cell transplantation in patients with systolic dysfunction: can it be done?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Hematopoietic stem cell transp ...... c dysfunction: can it be done?
@ast
Hematopoietic stem cell transp ...... c dysfunction: can it be done?
@en
type
label
Hematopoietic stem cell transp ...... c dysfunction: can it be done?
@ast
Hematopoietic stem cell transp ...... c dysfunction: can it be done?
@en
prefLabel
Hematopoietic stem cell transp ...... c dysfunction: can it be done?
@ast
Hematopoietic stem cell transp ...... c dysfunction: can it be done?
@en
P2093
P2860
P1476
Hematopoietic stem cell transp ...... c dysfunction: can it be done?
@en
P2093
Anne Blaes
Daniel Weisdorf
Peter Hurley
Suma Konety
P2860
P304
P356
10.1016/J.BBMT.2014.10.011
P577
2014-10-16T00:00:00Z